Godavari Drugs Ltd.

View in App
101.00 +0.52 ▲0.5%

25 April 2024, 04:01:00 PM
Volume: 12,601

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.godavaridrugs.com
Market Cap 76.06 Cr.
Enterprise Value(EV) 109.76 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 5.60 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 18.03 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 48.21 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.09 Calculated using Price: 101.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.75 Cr. 7,530,500 Shares
FaceValue 10
About Godavari Drugs Ltd.
The company's principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Godavari Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Godavari Drugs Ltd. Performance

View details >>
1 Day
+0.52%
1 Week
+2.83%
1 Month
+8.66%
3 Month
-2.71%
6 Month
+14.69%
1 Year
+30.90%
2 Year
+41.95%
5 Year
+357.01%
10 Year
+827.46%

Godavari Drugs Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 32.32 9.84 11.81 4.99 6.85 10.39 18.49 19.42 12.01
Return on Capital Employed (%) 32.3 15.77 16.89 11.01 12.14 11.8 17.58 18.35 14.53
Return on Assets (%) 14.7 3.17 3.41 1.4 1.77 2.54 4.72 5.45 3.4

Godavari Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 14 16 17 18 20 24 30 33 35
Non Curr. Liab. 5 5 6 9 9 12 16 14 14 14
Curr. Liab. 17 31 34 37 46 51 51 58 74 78
Minority Int.
Equity & Liab. 35 51 56 63 74 84 91 101 121 127
Non Curr. Assets 8 10 13 16 17 23 24 27 34 39
Curr. Assets 27 40 43 47 56 61 68 74 87 89
Misc. Exp. not W/O
Total Assets 35 51 56 63 74 84 91 101 121 127

Godavari Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 55 71 76 64 84 96 123 161 160 155
Other Income 0 0 1 1 0 0 0 0 1 1
Total Income 55 71 76 65 84 96 123 161 160 156
Total Expenditure -49 -67 -70 -60 -78 -90 -113 -150 -150 -144
PBIDT 6 5 6 5 6 6 10 12 11 12
Interest -1 -2 -3 -2 -3 -3 -3 -3 -4 -5
Depreciation -1 -1 -1 -1 -1 -1 -1 -2 -2 -2
Taxation -1 -1 -1 0 -1 0 -2 -2 -1 -1
Exceptional Items 0 0
PAT 4 1 2 1 1 2 4 5 4 4
Adjusted EPS 5 2 2 1 2 3 5 7 5 6

Godavari Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 2 -6 -5 5 4 4 6 1 11 13
Cash Fr. Inv. -2 0 -2 -3 -3 -2 -7 -1 -5 -9
Cash Fr. Finan. 0 6 7 -2 0 -1 0 0 -6 -4
Net Change 0 0 0 0 1 0 0 0 1 1
Cash & Cash Eqvt 0 0 1 1 2 2 1 2 2 3

Godavari Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 56.36 56.92 56.92 53.12 53.12 53.16 53.16 53.16 53.16
Public 43.64 43.08 43.08 46.88 46.88 46.84 46.84 46.84 46.84
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 5.16 5.11 5.11 1.25 0.12 1.25 1.25 1.25 1.25
No. of Shareholders (in Lacs)

Godavari Drugs Ltd. Announcements

View details >>
Tue, 16 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018
Sat, 30 Mar 2024
Closure of Trading Window
Closure of Trading Window
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Un-audited Financial Results for the Third Quarter ended December 31 2023

Godavari Drugs Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month

Godavari Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

Godavari Drugs Ltd. FAQ's

What is Godavari Drugs share price?
Can I buy Godavari Drugs shares now?
What is the Market Cap of Godavari Drugs?
What are the key metrics to analyse Godavari Drugs?
What is the 52 Week High and Low of Godavari Drugs?
What is the trend of Godavari Drugs share price?